Their findings revealed a positive correlation between AXL expression, TGF-β, and its receptor in disseminated prostate cancer cells, indicating a crucial crosstalk between TGF-β and the Gas6/Axl signaling pathways that regulate tumor dormancy. The gene discussed is TGFB1; the disease is Familial prostate cancer.